FGL1, as a cancer gene, is also an immune checkpoint gene, studies on the epigenetics of FGL1 may better and more comprehensively explore the function of FGL1 in lung cancer, providing a good theoretical basis for further designing targeted drugs for FGL1, the epigenetic changes of FGL1 may be the next therapeutic target for clinical transformation. Here, FGL1 is linked to lung carcinoma.